We recently published a list of 10 Stocks To Trade Without Tariffs And Interest Rate Fears. In this article, we are going to ...

Bloomberg reported late last month that Trump administration health officials were reevaluating a $590 million contract for ...

Vaccine makers Moderna Inc (NASDAQ:MRNA) and Novavax Inc (NASDAQ:NVAX) are facing selling pressure on Wednesday following reports suggesting the Trump administration will end support for Gavi.

“The companies told the PTAB in the petitions that Moderna’s patents include ‘unimaginably broad claims directed to a basic idea.’” Patent Trial and Appeal Board (PTAB) docket entries ...

Moderna (MRNA) stock is climbing 8% after the drug maker won a key court case and its CEO bought shares on the open market. MRNA's Court Victory A German court ruled that BioNTech (BNTX) and ...

MDV: Multidose vial; NA: Not available ... influenza vaccination campaign estimated that the total time to get a vaccine ready to be administered per patient was 87 s for MDVs and 49.71 s for ...

The court ordered BNTX and PFE to furnish information about the revenue that it generated from selling their mRNA vaccine, Comirnaty. Moderna is seeking damages based on all sales of Comirnaty ...

Why Moderna, Inc. (MRNA) Went Up On Tuesday? A scientist surrounded by vials and beakers in a modern laboratory, proudly displaying a vaccine. The amounts that Pfizer and BioNTech will have to pay ...